Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composite for treating infantile bronchial asthma and preparation method of medicine composite

A technology for bronchial asthma and a composition is applied in the field of pharmaceutical compositions for the treatment of bronchial asthma in children and the field of preparation thereof, which can solve the problems of long onset time, insignificant treatment effect of the disease, and unsuitability for clinical treatment, so as to avoid recurrence, improve Therapeutic effect, quick effect

Inactive Publication Date: 2017-09-15
芦建华
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, health care products with the same origin of medicine and food are generally suitable for health care products that prevent diseases before they happen, and their therapeutic effect on diseases is not obvious. In addition, health care products with the same origin of medicine and food have a relatively long onset time and are not suitable for clinical treatment. for

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composite for treating infantile bronchial asthma and preparation method of medicine composite

Examples

Experimental program
Comparison scheme
Effect test

preparation example

[0029] Preparation example: preparation of EM bacterial liquid

[0030] Prepare bacterial agent fermentation medium: 5% soluble starch, 1% yeast extract, 0.2% glutamine, 0.1% vitamin C, adjust pH to 7.0, sterilize, and set aside.

[0031] According to the inoculum amount of 5wt%, the EM original dew (Jiangxi Tianyi Biological Group) was inserted into the bacterial agent fermentation medium, and conventional fermentation (100rpm) was carried out at room temperature for 24 hours to obtain the EM bacterial liquid for future use.

Embodiment 1

[0032] Example 1 tablet

[0033] The bulk medicine of the tablet for treating children with bronchial asthma described in this embodiment consists of: 60g of red dates, 80g of soybeans, 30g of seaweed, 40g of white fungus, 20g of ginkgo, 20g of medlar, 10g of astragalus, 25g of Chinese yam, 6g of red bean, and EM bacterial liquid (accounting for 10wt% of the above-mentioned raw material total amount).

[0034] The preparation method of the tablet for the treatment of children's bronchial asthma described in the present embodiment may further comprise the steps:

[0035] (1) Get selected amounts of the red dates, soybeans, seaweed, white fungus, ginkgo, medlar, astragalus, yam and red bean, mix and pulverize;

[0036] (2) adding water accounting for 1 times the amount of the total amount of raw materials to the obtained mixed raw materials and mixing to obtain a raw material solution;

[0037] (3) adding a selected amount of the EM bacterial liquid to the raw material liquid,...

Embodiment 2

[0040] Embodiment 2 oral liquid

[0041] The bulk drug of the oral liquid for treating children with bronchial asthma described in this embodiment consists of: 100g of red dates, 50g of soybeans, 60g of seaweed, 20g of white fungus, 50g of ginkgo, 8g of medlar, 30g of astragalus, 15g of Chinese yam, 15g of red bean, and EM bacterial liquid (accounting for 20wt% of the above-mentioned raw material total amount).

[0042] The preparation method of the oral liquid for the treatment of infantile bronchial asthma described in the present embodiment may further comprise the steps:

[0043] (1) Get selected amounts of the red dates, soybeans, seaweed, white fungus, ginkgo, medlar, astragalus, yam and red bean, mix and pulverize;

[0044] (2) adding water accounting for 2 times the amount of the total amount of raw materials to the obtained mixed raw materials and mixing to obtain a raw material solution;

[0045] (3) adding a selected amount of the EM bacterial liquid to the raw ma...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of traditional Chinese medicine preparations, and particularly relates to a medicine composite for treating infantile bronchial asthma and a preparation method of the medicine composite. The medicine composite for treating the infantile bronchial asthma is prepared by taking red dates, soybean, seaweed, tremella, gingko, wolfberry, astragalus mongholicus, rhizoma dioscoreae and phaseolus calcaratus as raw materials, wherein the raw materials are medicinal and edible raw materials, and are food and medicines. An effect of the medicine composite for treating the infantile asthma is realized by utilizing performance among the raw materials and matching of active ingredients; the medicine composite has an extremely good treatment effect; a clinical cure rate of the medicine composite is up to 100%; the effect taking time is rapid; recurrence can be effectively avoided.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a pharmaceutical composition for treating children with bronchial asthma and a preparation method thereof. Background technique [0002] Bronchial asthma (bronchial asthma), referred to as asthma, is a reversible and obstructive respiratory disease characterized by recurrent cough, wheezing and dyspnea, accompanied by airway hyperresponsiveness. It is one of the common respiratory diseases in pediatrics. The incidence, prevalence and mortality of bronchial asthma have been on the rise in the past 30 years, seriously affecting human health. [0003] At present, bronchial asthma is considered to be a chronic airway persistent inflammatory disease, in which many cells play an important role, such as lymphocytes, eosinophils, mast cells, etc., accompanied by significantly increased non-specific airway responses, and Airway hyperresponsiveness (BHR) is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8945A61P11/06
CPCA61K36/02A61K36/07A61K36/16A61K36/48A61K36/481A61K36/725A61K36/815A61K36/8945A61K2236/19A61K2300/00
Inventor 芦建华
Owner 芦建华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com